---
$id: https://graph.org.ai/products/commodity/51271635
$type: Product
source: UNSPSC
code: "51271635"
title: "Ropivacaine hydrochloride"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ropivacaine hydrochloride

**UNSPSC Code**: 51271635
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a local anesthetic and amide with the molecular formula C17H26N2O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V910P86109, chemically known as 2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-propyl-, monohydrochloride, (s)- but more generally known as ropivacaine hydrochloride, which bears US NIH Compound Identifier 175804. European Medicines Agency schedules Ropivacaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04264MIG. Most nations, for tariff and trade purposes, schedule ropivacaine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, ROPIVACAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Ropivacaine hydrochloride bears US NLM identifiers UMLS ID C0771826 and NCI Concept Code C52198. SMILES: CCCN1CCCC[C@H]1C(=O)NC2C(CCCC2C)C.O.CL.

